Delta sleep-inducing peptide (DSIP)
US$ 21.55
oral.bpc 157 Oral BPC-157 Peptide People talk about BPC-157 like
Description
No adverse effects were noted in clinical trials (ulcerative colitis, phase II), and in toxicological studies, a lethal dose (LD1) could be not achieved (for review see [1,2,3,4,5,6,7,8,9,10,96,97,106,107,193])
It acts primarily on fat metabolism pathways, making it highly specific compared toHGH
Changes in both gross clinical exam and microscopic structure of cartilage in the affected joints indicates that AOD9604 is effective in treating the root cause of osteoarthritis and may work as both a treatment and preventative
Clinical data is sparse and inconsistent
